Regenerative Medicine
Cell & Gene Therapy
Health Care
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$54M
1 round on record
Latest round
$54M
Venture round · Jul 2024 · 2 yr ago
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2024 | $54M | — | News Powered by Cision |
Registers and programsofficial lists and records that name the company
| Legal entity | SmartCella Holding AB | its site |
Founders and leadersfrom filings, registers and the company's site
Scientific AdvisoryDirectorscompany's site
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.

Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…

Vira Regen develops noninvasive, gene-targeted electrostimulation devices for bone regeneration. OsteoVolt is in preclinical development…

About Us Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene…

Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.

A paradigm-shifting technology featuring KIR-based CAR construct that has been proven to reduce T cell exhaustion & kill solid tumor models…
News
SmartCella gains rights to advance cell therapy research for Parkinson's
The company signed the agreement with Karolinska Institutet
Read more
Report
XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart
Read more
Report
Aqua Metals Raises $13 Million from Leading Institutional Investor to Accelerate Commercialization and Strategic Growth
RENO, Nev., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling with its proprietary AquaRefining technology, today announced it has
Read more
Report
SmartCella raises EUR 50 million to accelerate growth and commercialization
SmartCella Holding AB (
Read more
Report
Catalent, Inc.: SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
SmartCella Holding AB ("SmartCella"), a global biopharma company developing and manufacturing cutting-edge cell therapy approaches for difficult-to-treat diseases, and Catalent, Inc., the leader in enabling
Read more
Report
SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies
SmartCella, through its business unit ProCella, has been approved by the Swedish Medicinal Product
Read more
Report
Tech stack
The technologies known for SmartCella, by layer.
Developer tools
Mandiant capa
Sign in to see how your skills match this stack
Sign In
People

Scientific Advisory
Directors
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Tumba
Tumba
Sweden
HQ
1 open roles 1 posted in 90 days 100% engineering
hires for Hardware
Alfred Nobels allé 150
Financials
Total raised
$54M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $54M | Details |






